Package 11673-687-27

Brand: up and up naproxen sodium pm

Generic: diphenhydramine hydrochloride, naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 11673-687-27
Digits Only 1167368727
Product NDC 11673-687
Description

1 BOTTLE in 1 CARTON (11673-687-27) / 80 TABLET, FILM COATED in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2022-01-25
Brand up and up naproxen sodium pm
Generic diphenhydramine hydrochloride, naproxen sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6590fad1-9ef5-4613-9d82-dc958d53f0a5", "openfda": {"unii": ["TC2D6JAD40", "9TN87S3A3C"], "rxcui": ["1550957"], "spl_set_id": ["c0769941-bcf2-4237-b70c-a79089ad5335"], "manufacturer_name": ["Target Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-687-27)  / 80 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "11673-687-27", "marketing_start_date": "20220125"}], "brand_name": "up and up naproxen sodium pm", "product_id": "11673-687_6590fad1-9ef5-4613-9d82-dc958d53f0a5", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "11673-687", "generic_name": "diphenhydramine hydrochloride, naproxen sodium", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "up and up naproxen sodium pm", "active_ingredients": [{"name": "DIPHENHYDRAMINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA208499", "marketing_category": "ANDA", "marketing_start_date": "20220125", "listing_expiration_date": "20261231"}